These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 28823831)
1. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells. Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831 [TBL] [Abstract][Full Text] [Related]
2. GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells. Sakaki H; Okada M; Kuramoto K; Takeda H; Watarai H; Suzuki S; Seino S; Seino M; Ohta T; Nagase S; Kurachi H; Kitanaka C Anticancer Res; 2015 Dec; 35(12):6607-14. PubMed ID: 26637876 [TBL] [Abstract][Full Text] [Related]
3. JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. Xun J; Wang D; Shen L; Gong J; Gao R; Du L; Chang A; Song X; Xiang R; Tan X Oncotarget; 2017 Mar; 8(13):21918-21929. PubMed ID: 28423536 [TBL] [Abstract][Full Text] [Related]
4. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin. Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671 [TBL] [Abstract][Full Text] [Related]
5. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504 [TBL] [Abstract][Full Text] [Related]
6. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
8. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells. Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780 [TBL] [Abstract][Full Text] [Related]
9. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1. Ma X; Zhang Y; Kang Y; Li L; Zheng W Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537 [TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer. Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994 [TBL] [Abstract][Full Text] [Related]
11. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092 [TBL] [Abstract][Full Text] [Related]
12. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y Int J Oncol; 2009 May; 34(5):1381-6. PubMed ID: 19360350 [TBL] [Abstract][Full Text] [Related]
13. Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane. Bayat Mokhtari R; Baluch N; Morgatskaya E; Kumar S; Sparaneo A; Muscarella LA; Zhao S; Cheng HL; Das B; Yeger H BMC Cancer; 2019 Aug; 19(1):864. PubMed ID: 31470802 [TBL] [Abstract][Full Text] [Related]
14. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
15. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337 [No Abstract] [Full Text] [Related]
16. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia. Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337 [TBL] [Abstract][Full Text] [Related]
17. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties. Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163 [TBL] [Abstract][Full Text] [Related]
18. GSKJ4 Protects Mice Against Early Sepsis via Reducing Proinflammatory Factors and Up-Regulating MiR-146a. Pan Y; Wang J; Xue Y; Zhao J; Li D; Zhang S; Li K; Hou Y; Fan H Front Immunol; 2018; 9():2272. PubMed ID: 30337925 [TBL] [Abstract][Full Text] [Related]
19. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]